Nivolumab
| CAS No. | 946414-94-4 | Cat. No. | BCP28580 |
| Name | Nivolumab | ||
| Synonyms | Opdivo; ONO-4538; BMS-936558; MDX1106;ONO 4538; BMS 936558; MDX 1106;ONO4538; BMS936558; MDX-1106; | ||
| Formula | M. Wt | ||
| Description | Nivolumab, marketed as Opdivo, is a humanized IgG4 anti-PD-1 monoclonal antibody used to treat cancer. Nivolumab works as a checkpoint inhibitor, blocking a signal that would have prevented activated T cells from attacking the cancer, thus allowing the immune system to clear the cancer. | ||
| Pathways | Apoptosis Pathway | ||
| Targets | PD 1/PD L1 | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.